Clinical Trials Directory

Trials / Completed

CompletedNCT02412865

Quit4Baby Evaluation

Developing and Scaling a Text Messaging Tool to Help Pregnant Smokers

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
505 (actual)
Sponsor
George Washington University · Academic / Other
Sex
Female
Age
14 Years – 44 Years
Healthy volunteers
Accepted

Summary

The goal of this project is to evaluate the effectiveness (Phase II) of a text-based program to be called Quit4Baby to support smoking cessation efforts of pregnant women who smoke. In Phase II, Dr. Abroms will conduct a randomized clinical trial among 500 pregnant smokers who have been recruited from users of text4baby - the first large scale mobile health application in the United States. Developed and operated by Voxiva and Healthy Mothers, Healthy Babies (HMHB)-collaborators in this program -text4baby is a free national service that has enrolled more than 800,000 pregnant women and mothers of infants 0-1 nationwide and delivered more than 150 million health messages to them including messages encouraging them not to smoke during pregnancy and referring them to quit lines. Hypothesis 1: Pregnant smokers who receive quit4Baby + text4Baby will demonstrate higher levels of knowledge about the dangers of second hand smoke and the benefits of smoking cessation for mothers and their infants than text4baby only users. Hypothesis 2: Pregnant smokers who receive quit4baby + text4baby will report significantly higher rates of calling a quit line, discussions with their health provider and/or use of cessation counseling than those who receive Text4baby alone. Hypothesis 3: Pregnant smokers who receive quit4baby + text4baby will have significantly more favorable quitting outcomes compared with text4baby alone.

Conditions

Interventions

TypeNameDescription
BEHAVIORALQuit4Baby
BEHAVIORALText4Baby

Timeline

Start date
2015-04-01
Primary completion
2016-02-01
First posted
2015-04-09
Last updated
2016-02-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02412865. Inclusion in this directory is not an endorsement.